期刊文献+
共找到38篇文章
< 1 2 >
每页显示 20 50 100
补肾壮阳类中药及保健食品中31种5型磷酸二酯酶抑制剂的高分辨四级杆飞行时间质谱定性定量检测方法 被引量:33
1
作者 于泓 胡青 +3 位作者 张甦 孙健 冯睿 季申 《中国药学杂志》 CAS CSCD 北大核心 2013年第15期1312-1318,共7页
目的基于高分辨四级杆飞行时间质谱(Q—TOF-MS),建立西地那非等31种5型磷酸二酯酶(PDE-5)抑制剂快速定性定量检测方法,并为未知衍生物的检测和鉴定提供参考。方法采用Agilent ZORBAX RRHD Eclipse Plus C18色谱柱,流动相0.1%甲... 目的基于高分辨四级杆飞行时间质谱(Q—TOF-MS),建立西地那非等31种5型磷酸二酯酶(PDE-5)抑制剂快速定性定量检测方法,并为未知衍生物的检测和鉴定提供参考。方法采用Agilent ZORBAX RRHD Eclipse Plus C18色谱柱,流动相0.1%甲酸-乙腈,梯度洗脱,流速0.4mL·min^-1;采用Q—TOF—MS作检测器,电喷雾源(ESI),正离子模式:与对照品保留时间、精确相对分子质量和二级碎片比对定性;根据提取离子流图峰面积与浓度关系定量。结果分析归纳了常见3种结构类型PDE-5抑制剂(西地那非、伐地那非和他达拉非类)ESI质谱裂解规律;31种PDE-5抑制剂分别在1-200、5-~400或20-600ng·mL^-1内呈良好线性关系(r≥0.9974),定量限0.07~37.82pg,回收率75.00%~124.56%,精密度均小于7.56%(n=6)。结论所建立方法灵敏、准确、高效。适用常见PDE-5抑制剂检测及同类未知衍生物的发现和快速鉴定。 展开更多
关键词 高分辨四级杆飞行时间质谱 5型磷酸二酯酶抑制剂 中药 保健食品 非法添加 定性 定量
原文传递
Herbal medicines and nonalcoholic fatty liver disease 被引量:15
2
作者 Hong Yao Yu-Jie Qiao +5 位作者 Ya-Li Zhao Xu-Feng Tao Li-Na Xu Lian-Hong Yin Yan Qi Jin-Yong Peng 《World Journal of Gastroenterology》 SCIE CAS 2016年第30期6890-6905,共16页
Nonalcoholic fatty liver disease(NAFLD), which is characterized by excessive fat accumulation in the liver of patients who consume little or no alcohol, becomes increasingly common with rapid economic development. Lon... Nonalcoholic fatty liver disease(NAFLD), which is characterized by excessive fat accumulation in the liver of patients who consume little or no alcohol, becomes increasingly common with rapid economic development. Long-term excess fat accumulation leads to NAFLD and represents a global health problem with no effective therapeutic approach. NAFLD is considered to be a series of complex, multifaceted pathological processes involving oxidative stress, inflammation, apoptosis, and metabolism. Over the past decades, herbal medicines have garnered growing attention as potential therapeutic agents to prevent and treat NAFLD, due to their high efficacy and low risk of side effects. In this review, we evaluate the use of herbal medicines(including traditional Chinese herbal formulas, crude extracts from medicinal plants, and pure natural products) to treat NAFLD. These herbal medicines are natural resources that can inform innovative drug research and the development of treatments for NAFLD in the future. 展开更多
关键词 herbal medicines Nonalcoholic fatty liver disease Natural product Traditional Chinese medicines REVIEW
下载PDF
中药产品甙肽对猪高热病防治效果分析 被引量:10
3
作者 许传田 张树光 +4 位作者 刘玉庆 胡北侠 颜世敢 鲁清贵 张秀美 《中国农学通报》 CSCD 北大核心 2010年第22期16-19,共4页
为找到一种有效防治猪高热病的方法,分别检测试验组和对照组猪血常规、血清生化指标、血清中细胞因子含量,以及甙肽产品对于预防和治疗猪高热病效果进行分析;结果表明,使用中药产品甙肽后,能够显著提高试验组猪的非特异性免疫力。进一... 为找到一种有效防治猪高热病的方法,分别检测试验组和对照组猪血常规、血清生化指标、血清中细胞因子含量,以及甙肽产品对于预防和治疗猪高热病效果进行分析;结果表明,使用中药产品甙肽后,能够显著提高试验组猪的非特异性免疫力。进一步证明了中药对于预防病毒性疾病可以起到独特效果。 展开更多
关键词 猪高热病 中药 非特异性免疫力 病毒性疾病
下载PDF
Integrating traditional Chinese (herbal) medicines into risk based regulation-With focus on non-clinical requirements to demonstrate safety 被引量:3
4
作者 Vivian S.W.Chan Fung 《Journal of Traditional Chinese Medical Sciences》 2020年第2期88-94,共7页
Within the public health sector of Hong Kong(China),there is a consensus around the important role of traditional Chinese medicines.For Hong Kong(China)to play a bridging role to bring Chinese medicines to the global ... Within the public health sector of Hong Kong(China),there is a consensus around the important role of traditional Chinese medicines.For Hong Kong(China)to play a bridging role to bring Chinese medicines to the global market requires a concerted effort from the government,academic institutes and industries.The release of the final version of the European Medicines Agencies guidance document,which details the acceptance of minimum requirements to nonclinical package in bibliographical applications,grants the opportunity for well-established and traditional herbal medicines to demonstrate an‘acceptable safe’status for registration in the European Union.It is anticipated that this minimum nonclinical package can be applied to demonstrate the safe use of many traditional Chinese medicines regardless of their eligibility to be registered under the simplified procedure within the European Union.This paper conceptualizes an integration of a simplified evaluation route for eligible proprietary Chinese medicines(pCm)with long history of use into the existing drug regulatory framework in Hong Kong(China).Such integration utilizing the minimum nonclinical package,based on bibliographical data or expert report,as proof of evidence to demonstrate safety for pCm with long history of use requires less demand in scientific resources.With Hong Kong(China)conducting‘first hand’review for eligible pCm,it provides an option for overseas and local pharmaceutical companies to register their products in Hong Kong(China)without the need to rely on issuance of Certificate of Pharmaceutical Product from other countries.This could bring eligible pCm with long history of use to reach international risk-based standard and to be marketed globally as‘medicines’to reach their full therapeutic potential.An important process to positioning Hong Kong(China)to compete with other countries in promoting importation and exportation of pCm to better serve the global health. 展开更多
关键词 Proprietary and traditional Chinese herbal MEDICINES INTERNATIONALIZATION NONCLINICAL Drug regulation and registration reform Certificate of pharmaceutical product
下载PDF
Investigation of Heavy Metal Contents in Traditional Chinese Herbal Medicine Peristrophe roxburghiana Collected from Northwest of Guangxi 被引量:2
5
作者 刘旭辉 李容 +2 位作者 郭俊 罗志勇 覃勇荣 《Agricultural Science & Technology》 CAS 2016年第12期2751-2756,2762,共7页
Objective] This study was conducted to evaluate the product quality and safety of Peristrophe roxburghiana_ col ected from different places in Hechi City, northwest of Gunagxi, so as to provide basic data for further ... Objective] This study was conducted to evaluate the product quality and safety of Peristrophe roxburghiana_ col ected from different places in Hechi City, northwest of Gunagxi, so as to provide basic data for further development and uti-lization of the characteristic plant resource P. roxburghiana. [Method] Contents of 9 kinds of heavy metals including Cd, Mn, Pb, Zn and Cu in the herb were deter-mined by the method of wet digestion-flame atomic absorption spectrophotometry and atomic fluorescence spectrometry, respectively. [Results] Heavy metal contents of Cd, Mn, Pb, Fe, Cu, Zn, As, Hg and Se were 1.62-17.25, 8.93-142.53, 4.37-18.43, 103.7-242.81, 2.55-5.35, 85.40-146.30, 0.07-0.54, 0.00-0.08 and 0.00-0.47 mg/kg, respectively. According to the national food safety standards and Green Trade Standards of lmporting &amp; Exporting Medicinal plants &amp; Preparations, the heavy metal contents of the P. roxburghiana_samples col ected from different coun-ties in Hechi City exceeded standards or at the critical values. Among which, Cd, Pb and Zn contents of the samples are seriously higher than the standards. [Con-clusion] Therefore, the impact of soil heavy metal pol ution on the safety of edible plants in the northwest of Guangxi should be highly concerned. 展开更多
关键词 Northwest of Guangxi Traditional Chinese herbal medicine Peristro-pheroxburghiana product quality and safety Heavy metal content
下载PDF
欧洲药草类制品市场之探讨 被引量:1
6
作者 陈鸿基 梁茜琪 《中华中医药杂志》 CAS CSCD 北大核心 2009年第7期959-965,共7页
在欧洲无论是药品、美容品或保健食品形式的药草类产品是越来越受欢迎。现时欧洲各国对这些产品的品质安全监管情况呈现大幅的差异。近年来欧盟开始制订新一轮法律,目的是使这些产品的监管能趋向一致。面对这些新法律加诸的约束和限制,... 在欧洲无论是药品、美容品或保健食品形式的药草类产品是越来越受欢迎。现时欧洲各国对这些产品的品质安全监管情况呈现大幅的差异。近年来欧盟开始制订新一轮法律,目的是使这些产品的监管能趋向一致。面对这些新法律加诸的约束和限制,中小型草药公司可能会感到难于应付。相反地,一些拥有雄厚资金和技术力量的大药厂却对投资药草类制品供应欧洲场市场显示出浓厚的兴趣。在可预见的将来,策略性联盟、收购合并及行业重组等活动将会频繁地发生。文章认为中国草药公司在面对激烈市场竞争情况下扩展欧洲业务仍然是大有可为的。同时针对一些边缘产品、标签、包装、健康与营养声明等条例和法规作了深入的分析,指出它们皆是中国草药商应特别关注的重要法律问题。 展开更多
关键词 草药药品 天然美容品 草药食品 边缘产品 标签法规 健康声明
原文传递
An Innovative Herbal Product for the Prevention of Osteoporosis
7
作者 梁秉中 郑景辉 陈一香 《Chinese Journal of Integrative Medicine》 SCIE CAS 2011年第10期744-749,共6页
Objective: To prevent the deterioration of osteopenia, a triple herb product Bo-gu Ling (补骨灵, ELP) was created for a clinical trial on post-menopausal women suffering from osteopenia. Methods: The design of the... Objective: To prevent the deterioration of osteopenia, a triple herb product Bo-gu Ling (补骨灵, ELP) was created for a clinical trial on post-menopausal women suffering from osteopenia. Methods: The design of the clinical trial was of randomized, double-blind, placebo-controlled nature. A total of 150 women aged 40-60 years, who were after menopause for at least 1 year and their lumbar spine bone mineral density (BMD) must be lower than 0.891 g/cm2, were recruited and randomly divided into the ELP group treated with ELP and the placebo group, with 75 in each group. The primary endpoint was the BMD of the lumbar spine that was assessed at baseline, 6 and 12 months after treatment. Secondary endpoints included peripheral quantitative computed tomography (pQCT) measurements of distal tibia and the changes in the quality of life (QOL). Results: The spine BMD of the ELP group was increased by 0.69% in the subjects who were more than 10 years after menopause. In contrast, the placebo group of the same stratum decreased by 0.61% (P=0.067). In the subjects with more than 10 years duration of menopause, the hip BMD increased by 0.21% in the ELP group, compared with a decrease of 0.52% in the placebo group (P=0.159). The tibia strengthstrain index was increased by 1.94% in the ELP group compared with 0.33% in the placebo group (P=0.047). Physical function of SF-36 QOL questionnaire was remarkably improved compared with the baseline, but did not show dominance over the placebo group. Conclusion: ELP showed potential benefit in improving BMD on the women who experienced over 10 years of menopause. 展开更多
关键词 prevention of osteoporosis herbal product bone mineral density
原文传递
江西省中药产业发展的同质化问题和对策研究——以江西省樟树市为例
8
作者 陈海清 谢俊俊 +1 位作者 陈雨萍 熊乐乐 《药品评价》 CAS 2023年第10期1171-1175,共5页
江西省樟树市是国内唯一授予“中国药都”的县级市,樟树的中药产业是江西省中药产业发展的代表和缩影。研究樟树中药产业发展中遇到的问题和瓶颈,对于探寻江西中药产业发展的路径和方向具有重要意义。该研究以实地调研数据为基础,发现... 江西省樟树市是国内唯一授予“中国药都”的县级市,樟树的中药产业是江西省中药产业发展的代表和缩影。研究樟树中药产业发展中遇到的问题和瓶颈,对于探寻江西中药产业发展的路径和方向具有重要意义。该研究以实地调研数据为基础,发现樟树中药产业主要问题是产品同质化严重;探讨了产品同质化的表现形式,分析产品同质化的影响因素及权重比例,为江西中药产业差异化发展探寻切入点和途径。 展开更多
关键词 中草药 中药产业 同质化 问题 对策 数据收集 江西
下载PDF
Treatment on Nature’s lap:Use of herbal products in the management of hyperglycemia
9
作者 Somdatta Giri Jayaprakash Sahoo +2 位作者 Ayan Roy Sadishkumar Kamalanathan Dukhabandhu Naik 《World Journal of Diabetes》 SCIE 2023年第4期412-423,共12页
Diabetes mellitus(DM)is characterized by persistently elevated blood glucose concentration that lead to multisystem complications.There are about 400 medicinal plants cited to have a beneficial effect on DM.We must ch... Diabetes mellitus(DM)is characterized by persistently elevated blood glucose concentration that lead to multisystem complications.There are about 400 medicinal plants cited to have a beneficial effect on DM.We must choose products wisely based on data derived from scientific studies.However,a major obstacle in the amalgamation of herbal medicine in modern medical practices is the lack of clinical data on its safety,efficacy and drug interaction.Trials of these herbal products often underreport the side effects and other crucial intervention steps deviating from the standards set by Consolidated Standards of Reporting Trials.Due to a lack of knowledge of the active compounds present in most herbal medicines,product standardization is difficult.Cost-effectiveness is another issue that needs to be kept in mind.In this mini-review,we focus on the antihyperglycemic effect of herbal products that are commonly used,along with the concerns stated above. 展开更多
关键词 herbal product HBA1C Diabetes mellitus Active compound Natural therapy COST-EFFECTIVENESS
下载PDF
Inhalation therapy for pulmonary fibrosis:chemical medicines and herbal medicines
10
作者 Xiao-Fen Xie Yao Lu +4 位作者 Xu-Shan Chen Gulizeba Muhetaer Hao Tao Hang Li Han-Jiao Liu 《TMR Modern Herbal Medicine》 2023年第3期31-43,共13页
Pulmonary fibrosis(PF)is a chronic,progressive,and irreversible pulmonary interstitial disease with unclear pathogenesis.Currently,there are few treatment options for managing PF.Inhalation therapy,as a routine treatm... Pulmonary fibrosis(PF)is a chronic,progressive,and irreversible pulmonary interstitial disease with unclear pathogenesis.Currently,there are few treatment options for managing PF.Inhalation therapy,as a routine treatment for respiratory diseases,is being used to study the treatment of PF.Some herbal medicines and their active ingredients have been reported to have anti-PF effects.This review aims to provide an overview of the latest developments in inhalation therapy,focusing on the utilization of chemical medicines and herbal medicines for the treatment of PF in both clinical practice and basic research.The inhalation of chemical drugs such as pirfenidone,nintedanib,N-acetylcysteine,and interferon-γhas been shown to demonstrate anti-PF effects.Additionally,the inhalation of various natural products derived from herbal medicines,encompassing polyphenols,alkaloids,flavonoids,saponins,terpenoids,and herbal extracts,contributes to the therapeutic management of PF through diverse mechanisms.The inhalation of both chemical and herbal medicines presents promising advantages in the treatment of PF.Further clinical trials are required to investigate the effectiveness,safety,and mechanism of action of inhalation therapy utilizing natural products derived from herbal medicines. 展开更多
关键词 herbal medicine NEBULIZER pulmonary fibrosis natural product INHALATION
下载PDF
某院中药注射剂的临床应用分析
11
作者 曾繁涛 李成 +3 位作者 王蔓琳 陈旎旎 刘君波 杨惠 《现代医药卫生》 2012年第15期2281-2283,2285,共4页
目的调查分析深圳市第四人民医院中药注射剂的临床使用情况,为临床更合理应用该类药物提供参考。方法对该院2011年中药注射剂的销售金额、用药频度及2012年1—3月使用中药注射剂的住院患者的病历进行回顾性分析。另外,对其所用的中药注... 目的调查分析深圳市第四人民医院中药注射剂的临床使用情况,为临床更合理应用该类药物提供参考。方法对该院2011年中药注射剂的销售金额、用药频度及2012年1—3月使用中药注射剂的住院患者的病历进行回顾性分析。另外,对其所用的中药注射剂说明书进行规范化统计。结果该院2011年中药注射剂销售金额逐季增长,单品销售金额排序每季度有所不同,但排位变化不大。2012年1—3月中药注射剂合理使用率为74.39%。结论该院中药注射剂销售金额所占比重较小,销售金额与用药频率同步性欠佳。中药注射剂总体使用情况较为合理,主要用于改善微循环及提高免疫力。其说明书还可以进一步完善。 展开更多
关键词 中草药 注射剂 产品监测 售后 药物利用 病案 中药注射剂 产品标签 销售金额 病历分析
下载PDF
Anti-tumor effects and cellular mechanisms of Pistacia atlantica methanolic extract against Ehrlich solid tumor in mice
12
作者 Aishah E.Albalawi Norah A.Althobaiti +1 位作者 Reem Hasaballah Alhasani Sultan F.Alnomasy 《Asian Pacific Journal of Tropical Biomedicine》 SCIE CAS 2022年第2期69-77,共9页
Objective:To assess the anti-tumor effects of Pistacia atlantica methanolic extract(PAME)compared with cyclophosphamide against Ehrlich solid tumors in mice.Methods:Swiss albino mice(n=40)were divided into five groups... Objective:To assess the anti-tumor effects of Pistacia atlantica methanolic extract(PAME)compared with cyclophosphamide against Ehrlich solid tumors in mice.Methods:Swiss albino mice(n=40)were divided into five groups:normal control mice,mice with Ehrlich solid tumors treated with normal saline,mice with Ehrlich solid tumors treated with cyclophosphamide intraperitoneally once a day for 14 d,or 50mg/kg or 100 mg/kg PAME orally once a day for 14 d.Tumor growth inhibition,body weight,tumor markers,liver and kidney enzymes,oxidative stress markers,antioxidant enzymes,tumor necrosis factor-alpha level(TNF-α),and apoptosis-regulatory gene expression were evaluated.Results:Treatment of mice bearing Ehrlich solid tumors with PAME at 50 and 100 mg/kg orally significantly decreased tumor volume,body weight,tumor markers,liver and kidney enzymes,oxidative stress markers and TNF-αlevel in comparison with mice with Ehrlich solid tumors receiving normal saline.whereas PAME at 50 and 100 mg/kg/day significantly elevated the level of antioxidant enzymes(P<0.05).Conclusions:Pistacia atlantica methanolic extract has potent antitumor activity in mice.Therefore,the extract might be considered as an alternative anticancer agent against tumors,however,additional studies especially in the clinical setting are required to confirm this finding. 展开更多
关键词 CANCER Ehrlich solid tumors TREATMENT Pistacia atlantica herbal medicines Natural product in vivo MICE
下载PDF
Potential use of Clerodendrum capitatum extracts and its formulation for control of three major stored product beetles
13
作者 Jacobs Mobolade Adesina Anjanappa Raghavendra +1 位作者 Yallappa Rajashekar Thomas Inomisan Ofuya 《Food Quality and Safety》 SCIE CSCD 2019年第3期179-185,共7页
Objective:Insecticidal activity of Clerodendrum capitatum extracts against the stored product insect pest,Sitophilus oryzae(L.),Rhyzopertha dominica(F.),and Tribolium castaneum(Herbst)were investigated.Materials and M... Objective:Insecticidal activity of Clerodendrum capitatum extracts against the stored product insect pest,Sitophilus oryzae(L.),Rhyzopertha dominica(F.),and Tribolium castaneum(Herbst)were investigated.Materials and Methods:Hundred grams of C.capitatum powder was sequentially extracted with a series of solvents of increasing polarity in a Soxhlet apparatus and the extracts were concentrated on rotary evaporator to make it solvent free and the residue dissolved in a known volume of methanol and the solution was assayed for insecticidal activity by the fumigant toxicity.Hexane extract which showed maximum activity was selected for the preparation of herbal formulation and for its insecticidal properties and phytotoxicity.The herbal formulation obtained from leaves of C.capitatum was investigated by GCMS and GC/FID.Results:Clerodendrum capitatum ethyl extract had a very strong repellent activity to adults of all three major stored grain insects and was significantly repellent at a 1.58 mg/cm^(2).The hexane extract(oil)had high fumigant activity with LC_(50) values in the range between 25 and 32μg/L.A total of 14 components representing 97.8%of the formulation were identified and the main compounds in the formulation were found to be 2-Heptanone,3-methyl(33.9%)and Hexahydrofarnesyl acetone(25.3%)followed by 3-Dodecen-1-al(10.2%)and 8-Methyl-1-undecene(4.9%).Further,herbal formulation was found to be highly toxic to mixed age cultures of all three major stored grain insect pests which recorded 80%-90%mortality at dose of 200μg/L in 24 h exposure,where as 100%mortality achieved at dose of 200μg/L in 72 h exposure,respectively.Conclusion:The results indicate that extracts and formulation of C.capitatum has the potential to be developed in to a natural insecticide or repellent for controlling of stored product beetles. 展开更多
关键词 FUMIGATION gas chromatography mass spectrometry(GCMS) herbal formulation repellence stored product beetles
原文传递
中草药及其提取物的作用及在牛生产中的应用研究进展 被引量:18
14
作者 李明博 张龙舟 +3 位作者 刘环宇 金远铭 高青山 崔莲花 《饲料研究》 CAS 北大核心 2021年第16期148-150,共3页
中草药具有低药物残留、无毒、无不良反应和无抗药性等优点。研究生产无抗生素残留的牛肉及奶产品的具有重要意义。文章综述中草药及其提取物的作用和对牛的生长性能、免疫力、抗应激反应和畜产品品质的影响,为解决抗生素残留问题、生... 中草药具有低药物残留、无毒、无不良反应和无抗药性等优点。研究生产无抗生素残留的牛肉及奶产品的具有重要意义。文章综述中草药及其提取物的作用和对牛的生长性能、免疫力、抗应激反应和畜产品品质的影响,为解决抗生素残留问题、生产绿色安全的牛肉及奶产品提供参考。 展开更多
关键词 中草药及其提取物 饲料添加剂 畜产品品质
下载PDF
中国石斛产业发展现状分析与考量 被引量:17
15
作者 杨明志 单玉莹 +2 位作者 陈晓梅 张朝凤 李振坚 《中国现代中药》 CAS 2022年第8期1395-1402,共8页
石斛作为我国“九大仙草”之首,发展势头迅猛,种植面积居草本中药材第21名,已成为我国的大宗药材。发布我国石斛产业最新数据,对目前我国石斛种质资源进行系统梳理,概括分析石斛产业发展脉络和历程,梳理与石斛产业发展息息相关的药食同... 石斛作为我国“九大仙草”之首,发展势头迅猛,种植面积居草本中药材第21名,已成为我国的大宗药材。发布我国石斛产业最新数据,对目前我国石斛种质资源进行系统梳理,概括分析石斛产业发展脉络和历程,梳理与石斛产业发展息息相关的药食同源、新资源食品等政策,为后期石斛产业的发展和产品开发提供参考。我国共有石斛野生资源92种,石斛产业种植总面积达45.4万亩(1亩≈666.67 m2),综合产值逾500亿元。石斛种植面积较大的省份有云南、贵州、浙江等,石斛主产区为云南德宏、保山,浙江乐清,安徽霍山,贵州赤水、安龙、锦屏等。药用石斛种类主要为铁皮石斛、金钗石斛、霍山石斛、紫皮石斛等。 展开更多
关键词 兰科 石斛 中药 产品开发
下载PDF
经典名方中连翘的本草考证 被引量:13
16
作者 李石飞 张立伟 詹志来 《中国实验方剂学杂志》 CAS CSCD 北大核心 2022年第10期111-122,共12页
通过查阅历代相关本草、医籍和方书,笔者对经典名方中所用连翘的名称、基原、药用部位、商品规格、性味功效、产地、品质评价及采收加工方法等进行了本草考证,结果表明连翘药材在宋代以前来源为藤黄科湖南连翘Hypericum ascyron及其同... 通过查阅历代相关本草、医籍和方书,笔者对经典名方中所用连翘的名称、基原、药用部位、商品规格、性味功效、产地、品质评价及采收加工方法等进行了本草考证,结果表明连翘药材在宋代以前来源为藤黄科湖南连翘Hypericum ascyron及其同属多种植物,多部位入药;宋朝以后转为木犀科连翘Forsythia suspensa的果实。从明代开始,根据采收时间不同,连翘分为青翘和老翘2个规格和2个用法。根据考证结果,建议在经典名方开发过程中对连翘运用时参考以下意见:(1)明清以来经典名方选择木犀科连翘作为基原;(2)方剂出处若无特殊要求,建议明清以来经典名方中选用老翘;(3)无论用青翘还是老翘,青翘采收时间应该是在阳历7月下旬至8月上旬,老翘则在9月份期间采收连翘果实后去子用壳。 展开更多
关键词 经典名方 连翘 本草考证 木犀科 药用部位 商品规格 功效 采收加工
原文传递
基于“欧盟草药专论”解析中药欧盟注册关键问题 被引量:12
17
作者 瞿礼萍 王文珺 +2 位作者 周祯祥 张廷模 邹文俊 《中草药》 CAS CSCD 北大核心 2014年第24期3509-3514,共6页
欧盟2004/24/EC法令针对传统草药药品实行简化注册程序,很大程度降低了草药药品上市门槛,但法令为其额外设定的注册条件,如草药在欧盟至少药用15年历史要求、适应症限制、给药途径限制等,对非欧洲本土来源的中药产品而言仍面临诸多挑战... 欧盟2004/24/EC法令针对传统草药药品实行简化注册程序,很大程度降低了草药药品上市门槛,但法令为其额外设定的注册条件,如草药在欧盟至少药用15年历史要求、适应症限制、给药途径限制等,对非欧洲本土来源的中药产品而言仍面临诸多挑战。鉴于"欧盟草药专论"的评价与草药药品简化注册中安全性和有效性的审评标准基本一致,首次从欧盟草药专论的角度,跟踪欧盟草药专论最新评价进展,对影响欧盟草药专论建立的关键因素以及中药产品简化注册过程中的关键问题进行深入分析,并提出建议与对策,以期为中药产品欧盟注册提供一定指导和参考。 展开更多
关键词 欧盟2004/24/EC法令 欧盟草药专论 中药产品 欧盟注册 安全性
原文传递
恩施州中药材类特色农产品优势区创建的思考 被引量:12
18
作者 孙元鹏 袁知洋 +2 位作者 刘于思 熊晚珍 孙志国 《湖北农业科学》 2019年第11期154-158,共5页
创建特色农产品优势区,是党中央、国务院新的重大决策部署,是深入推进农业供给侧结构性改革与农业高质量发展、实施乡村振兴战略与兴旺乡村优势特色产业的重要创新举措。在介绍特色农产品优势区的由来与进展的基础上,分析了全国中药材... 创建特色农产品优势区,是党中央、国务院新的重大决策部署,是深入推进农业供给侧结构性改革与农业高质量发展、实施乡村振兴战略与兴旺乡村优势特色产业的重要创新举措。在介绍特色农产品优势区的由来与进展的基础上,分析了全国中药材类中国特色农产品优势区概况,研究恩施州中药材资源与产业优势,探讨其道地药材类国家级与省级特色农产品优势区创建的策略,并提出了10点建议。 展开更多
关键词 中药材 特色农产品优势区 恩施州
下载PDF
天然草本(植物)饮料新品研发与市场趋势的思考 被引量:11
19
作者 朱向东 《中国食品添加剂》 CAS 北大核心 2012年第5期192-202,共11页
从药食同源的概念形成与经营基础,天然草本(植物)饮料的定义与目前发展概况、新品研发思路、法规风险、品牌建设、以及市场趋势等多方面、多角度地阐述了天然草本(植物)饮料新品研发与市场趋势的思考。中华草本饮料有着丰富的文化底蕴... 从药食同源的概念形成与经营基础,天然草本(植物)饮料的定义与目前发展概况、新品研发思路、法规风险、品牌建设、以及市场趋势等多方面、多角度地阐述了天然草本(植物)饮料新品研发与市场趋势的思考。中华草本饮料有着丰富的文化底蕴与良好的市场营销基础,市场前景广阔,目前处于成长上升阶段,在营销上要关注品牌建设和消费理念的引导,在食品工业越来越倡导天然、健康的今天,天然草本(植物)饮料在国内及国际市场必将大有所为。结合饮料市场与食品科技发展的实际,建议天然草本(植物)饮料的新品研发上要关注中国要素、健康要素、愉悦要素、创新要素等四大构思要素;同时关注新品的原料策略、产品结构策略、产品开拓策略、产品开发成本策略、市场定位策略、生产成本策略等六大开发策略。结合自身的工作实际谈到食用香精在饮料工业中的定位和作用,并列举了在饮料工业中的应用实例。 展开更多
关键词 草本饮料 新品研发 构思要素 开发策略 食用香精 市场趋势
下载PDF
突破中药欧盟注册障碍的关键因素分析 被引量:10
20
作者 张建武 邱琼 《中国中药杂志》 CAS CSCD 北大核心 2014年第15期2972-2977,共6页
欧盟是中药国际化的桥梁,中药在欧盟成功注册具有重要的战略意义。该文简要回顾了10年来欧盟植物药政策的进展以及品种的批准情况,系统研究了欧盟植物药注册的政策法规,分析了一些中药欧盟注册的典型案例,重点从注册类别、审批程序、审... 欧盟是中药国际化的桥梁,中药在欧盟成功注册具有重要的战略意义。该文简要回顾了10年来欧盟植物药政策的进展以及品种的批准情况,系统研究了欧盟植物药注册的政策法规,分析了一些中药欧盟注册的典型案例,重点从注册类别、审批程序、审批部门、申报品种、申报企业5个方面分析影响注册成败的关键因素,并提出了突破欧盟注册障碍的相应对策与建议,以期为我国中药在欧盟成功注册和实施中药国际化战略提供参考和借鉴。 展开更多
关键词 中药 欧盟 药品注册 植物药 政策法规 关键因素
原文传递
上一页 1 2 下一页 到第
使用帮助 返回顶部